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Abstract: Biomaterial scaffolds meant to function as support-
ing structures to osteogenic cells play a pivotal role in bone
tissue engineering. Recently, we synthesized an aliphatic poly-
urethane (PU) scaffold via a foaming method using non-
toxic components. Through this procedure a uniform inter-
connected porous structure was created. Furthermore,
hydroxyapatite (HA) particles were introduced into this pro-
cess to increase the bioactivity of the PU matrix. To evaluate
the biological performances of these PU-based scaffolds,
their influence on in vitro cellular behavior and in vivo bone
forming capacity of the engineered cell-scaffold constructs
was investigated in this study. A simulated body fluid test
demonstrated that the incorporation of 40 wt % HA particles
significantly promoted the biomineralization ability of the PU
scaffolds. Enhanced in vitro proliferation and osteogenic dif-
ferentiation of the seeded mesenchymal stem cells were also
observed on the PU/HA composite. Next, the cell-scaffold
constructs were implanted subcutaneously in a nude mice
model. After 8 weeks, a considerable amount of vascularized
bone tissue with initial marrow stroma development was
generated in both PU and PU/HA40 scaffold. In conclusion,
the PU/HA composite is a potential scaffold for bone regener-
ation applications. VC 2014 Wiley Periodicals, Inc. J Biomed Mater
Res Part A: 103A: 2251–2259, 2015.
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INTRODUCTION
Since the concept of tissue engineering was introduced,
researchers have been seeking a solution for bone repair
and regeneration by combining the three key factors, that is
a porous scaffold, exogenous stem cells, and biological
cues.1 Essentially, the choice of a biomaterial as a scaffold is
critical to the success of bone tissue engineering.2 It is
widely accepted that an optimal scaffold should possess a
porous and biologically compatible framework onto which
bone-forming cells can attach, function, and eventually form
new bone tissue.3
Recently, polyurethanes (PUs) gained popularity and
have been investigated as scaffold material. A typical PU is a
block copolymer consisting of a hard segment contributed
by isocyanates and a soft segment formed by polyether or
polyester polyols. For that reason, the material properties of
PU, such as mechanical strength, biodegradability, and cyto-
compatibility, can be easily modified by adjusting the com-
ponents of the hard and soft segments during PU
synthesis.4,5 For instance, a PU synthesized from aliphatic
diisocyanate, for example isophorone diisocyanate (IPDI),
non-toxic castor oil, and 1,4-butanediol (BDO) gives rise to
non-toxic degradation products, which is more desirable to
be used as a scaffold material than the conventional PUs
made from aromatic diisocyanates.6,7 However, like most
synthetic polymers, PUs lack bioactive groups to facilitate
biomineralization. The most common strategy to counteract
the poor bioactivity is by introducing bioactive ceramics, for
example hydroxyapatite (HA) particles, into the PU matrix
during the polymerization process.8,9 Due to the presence of
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polar groups in the molecular chain, PUs have relatively
high affinity to HA.10
Another attractive feature of PUs is their preference to
spontaneously foaming during the copolymerization process,
which facilitates a one-step process of making porous scaf-
folds. For instance, water, which is either unavoidably pres-
ent in the reaction mixture or added intentionally during
the copolymerization process, reacts with the isocyanate
causing the release of CO2 gas. CO2 gas creates bubbles and
eventually leads to foaming. Our previous study has demon-
strated that a mild foaming process could be achieved to
allow the formation of a uniform porous PU structure, by
carefully choosing a low reaction rate isocyanate.11 We also
demonstrated that nanosized HA particles could be added
into this process, resulting in the formation of a porous PU/
HA composite scaffold with good dispersion and high occu-
pancy of HA particles.11,12
In this study, we aimed to further test the biological per-
formance of such PU/HA scaffolds in comparison to HA free
PU scaffolds, including the scaffold effect on cellular behav-
ior and in vivo bone forming capacity of the engineered cell-
scaffold constructs. Firstly, the scaffolds were immersed in
simulated body fluid (SBF) to test the biomineralization
capacity. Furthermore, rat bone marrow derived mesenchy-
mal stem cells (MSCs) were seeded onto the scaffolds, and
the cell viability and the osteogenic capacity were tested in
vitro. Finally, the efficacy of bone formation on the cell-
scaffold constructs was evaluated in vivo after subcutaneous
implantation in nude mice.
MATERIALS AND METHODS
Scaffold fabrication and morphology characterization
All the reagents were of analytic grade and purchased from
Kelong Co. (Chengdu, China), except that castor oil and IPDI
were obtained from Aladdin Co. (Shanghai, China). Both cas-
tor oil and BDO were dehydrated under decompression
with a vacuum of 1330 Pa at 120C. IPDI was preserved in
a refrigerator before use. Nanosized HA slurry was prepared
by wet synthesis as previously described,13 then spray-dried
to particles of 5–15 lm in diameter for further
experiments.
The PU and PU/HA scaffolds were prepared by copoly-
merization and simultaneous foaming following our previ-
ously reported method.11 The reaction was performed in a
250 mL three-necked round-bottom flask under a dry nitro-
gen atmosphere. Firstly, 38 g castor oil, and a certain
amount of HA powders, were put into the flask and stirred
uniformly. Subsequently, 11.2 g IPDI was added drop-wise
into the HA/castor oil mixture and the reaction was kept
for 4 h to form the prepolymer. Then 4.5 g BDO was used
as a chain extender to crosslink the prepolymer and 0.9 g
deionized water was added in the crosslinked prepolymer
by stirring for 5 min. The mixture was placed in an oven at
120C for 4 h accompanied with simultaneous foaming,
after which the three-dimensional porous bulk scaffold was
obtained. Three types of scaffolds were prepared based on
the amount of HA. They were named as PU, PU/HA20, and
PU/HA40 with the PU:HA weight ratios of 100:0, 80:20, and
60:40, respectively. For all three types of scaffolds, the over-
all porosity was 78–81%.11
Disk-shaped samples with a diameter of 6 mm and a
thickness of 2.5 mm were punched out of the bulk scaffolds.
In order to achieve further exposure of the HA particles on
the surfaces, all types of scaffolds were immersed in 20M
NaOH solution for 5 days under gentle agitation, as NaOH
has the erosive effect on PU.14 After that all scaffolds were
cleaned thoroughly in deionized water and freeze-dried
before being used in the further experiments. The scaffold
morphology was examined by scanning electron microscopy
(SEM; JEOL6340F, Tokyo, Japan) after being sputter-coated
with gold.
Simulated body fluid immersion test
SBF immersion test was used to evaluate the biomineraliza-
tion behavior of the scaffolds. The recipe of SBF was
adopted from Kokubo and Takadama15 and the pH value of
the solution was adjusted to 7.4 after complete preparation.
Immersion studies were performed by incubating each sam-
ple in 10 mL SBF solution in a 15-mL tube (n5 3). All tubes
were placed in a water bath at 37C under continuous shak-
ing. After immersion periods of 1 and 4 weeks, the scaffolds
were gently washed with deionized water and freeze-dried.
SEM and elemental analysis of the deposits was carried out
using a Philips XL30 scanning electron microscope (Eind-
hoven, The Netherlands) equipped with an energy disper-
sive spectrometer (EDS, AMETEK Materials Analysis
Division, Mahwah, NJ) after the samples were sputter-
coated with gold (Cressington 108A, Watford, UK). The
accelerating voltage was 10 keV and the working distance
was 10 mm. EDS analysis provided information on the dis-
tribution of elements of interest (Ca and P) in the analyzed
area.
Cell isolation and seeding
Rat MSCs were isolated from 6-week-old male Wistar rats
after the approval from Radboud University Nijmegen Ani-
mal Ethics Committee. Briefly, two femora of each rat were
extracted and the epiphyses were cut off. MSCs were
flushed out of the remaining diaphyses using the primary
cell culture medium, consisting of alpha Minimal Essential
Medium (aMEM; Gibco, Grand Island, USA) supplemented
with 10% fetal bovine serum (FBS; Sigma, St. Louis, USA),
100 U/mL penicillin and 100 lg/mL streptomycin (Gibco).
The flush-out was cultured for two days in a humidified
incubator (37C, 5% CO2), after which the medium was
refreshed to remove non-adherent cells. Prior to detaching
the cells, they were cultured for an additional three days.
Then, the cells were detached using trypsin/EDTA (0.25%
wt/vol trypsin, 0.02% wt/vol EDTA; Sigma) and counted.
The PU scaffolds for cell culture experiments were steri-
lized by autoclave and pre-wetted in primary cell culture
medium overnight. For cell seeding, 5 3 104 cells were sus-
pended in 50 mL medium and statically seeded onto each
scaffold. All scaffolds were placed in 24-well non-adherent
culture plates (1 scaffold per well) and incubated for 3 h in
a humidified incubator (37C, 5% CO2) allowing the initial
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cell attachment to the scaffolds. Subsequently, osteogenic
medium was added, which contained 50 lg/mL ascorbic
acid (Sigma), 10 nM dexamethasone (Sigma) and 10 mM
sodium b-glycerophosphate (Sigma) on the basis of the pri-
mary culture medium. Scaffolds were maintained in culture
for 24 days, with the cell culture medium being refreshed
twice per week. Cell viability, DNA amount, alkaline phos-
phatase (ALP) activity, and osteogenic gene expression were
tested.
Cell viability
LIVE/DEADVR Assay (Invitrogen) was used to assess cell viabil-
ity after 24 h of cell seeding. The cell-scaffold constructs were
washed in phosphate buffered saline (PBS) and exposed to
calcein AM/ethidium homodimer-1/PBS working solution for
30 min at 37C according to the manufacturer’s instructions.
Dye uptake was detected by using an automated fluorescent
microscope (Axio Imager Microscope Z1; Carl Zeiss Micro
Imaging GmbH) with a wave length of 488 nm for visualizing
the live cells (green) and 568 nm for the dead cells (red).
DNA content and ALP activity
DNA content (n5 3) was quantified by PicoGreen assay
(Quant-iT PicoGreen dsDNA, Invitrogen) after 4, 8, 16, and
24 days of osteogenic culture condition. After the culture
medium was removed, scaffolds were washed twice with
PBS. Cells were harvested by placing the cell-scaffold con-
structs in a 1.5-mL tube. One milliliter of deionized water
was added to each sample, after which two freeze-thaw
cycles and ultrasonication were performed. One hundred
microliters cell lysate or DNA standard from the PicoGreen
assay kit was added to 100 lL freshly made working solu-
tion in the wells. The results were read using a fluorescence
microplate reader (Bio-Tek Instruments, Abcoude, The Neth-
erlands) with an excitation wavelength at 485 nm and an
emission wavelength at 530 nm.
The ALP activity (n5 3) was measured as a marker for
early osteogenic differentiation using the same samples as
for the DNA assay. Eighty microliters of cell lysate or stand-
ard (serial dilutions of 4-nitrophenol at the concentrations
of 0–25 nM) and 20 lL of buffer solution (5 mM MgCl2,
0.5M 2-amino-2-methyl-1-propanol) were added into a 96-
well plate. Then, 100 lL of substrate solution (5 mM para-
nitrophenylphosphate) was added into all wells. Subse-
quently, the plate was incubated for 1 h at 37C before the
reaction was stopped by adding 100 lL of 0.3M NaOH. The
plate was read in an ELISA reader (Bio-Tek Instruments) at
405 nm. ALP activity results were normalized by the
amount of DNA.
RNA extraction and real-time PCR analysis
To analyze the expression of osteogenic-related genes of the
cells seeded on each scaffold, a real-time polymerase chain
reaction (PCR) was performed. Total RNA was extracted
using TrizolVR method (Invitrogen) after 4 and 8 days of cul-
turing. Briefly, scaffolds with cells were washed with PBS
before 1 mL of TrizolVR solution was added. The cell extract
was then collected, mixed with chloroform, and centrifuged.
Only the upper aqueous phase was collected and mixed
with equal amount of isopropanol. After 10 min of incuba-
tion at room temperature, the extract was centrifuged and
washed twice with 75% alcohol. The RNA pellet was dis-
solved in RNA free water and the total RNA concentration
was measured with spectrophotometer (NanoDrop 2000,
Thermal scientific, Wilmington, USA).
First strand cDNA was reverse transcribed from RNA
using the SuperScript First-Strand Synthesis System kit
(Invitrogen). Afterwards cDNA was further amplified and
the expression of specific genes was quantified using IQ
SYBR Green Supermix PCR kit (BioRad, Hemel Hempstead,
United Kingdom) in a real-time PCR (BioRaD, CFX96TM
real-time system). Osteogenic markers expressed on RNA
level were evaluated, including osteocalcin (Oc), bone sialo-
protein (Bsp), and runt-related transcription factor 2
(Runx2) (Table I). The expression levels were analyzed and
compared to the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (Gapdh). The specificity of the
primers was tested separately before the real-time PCR
reaction. The expression of the tested genes was calculated
via the 22DDCt method15 and the PU scaffolds were used as
the reference group.
In vivo implantation
Based on the in vitro results, two types of scaffolds, PU
and PU/HA40 with distinct biological properties were
sterilized by autoclave and selected for the in vivo study.
The protocol was approved by the Animal Ethical Commit-
tee of the Radboud University Nijmegen Medical Centre
(Approval no: RU-DEC 2010-254) and the national guide-
lines for the care and use of laboratory animals were
applied. Before in vivo implantation, 250,000 cells were
seeded on each scaffold and cultured for 5 days in vitro.
Afterwards, the cell-scaffold constructs were implanted
subcutaneously in three male nude mice (HsdCpb:NMRI-
nu, Harlan). Surgery was performed under general inhala-
tion anesthesia with a combination of isoflurane, nitrous
oxide, and oxygen. All mice received analgesic before and
after the surgery. The back of the mice was shaved and dis-
infected with povidone-iodine. Subsequently, four small
TABLE I. Overview of the Primer Sequences
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longitudinal incisions were made. Lateral to each incision, a
subcutaneous pocket was created. A cell-scaffold construct and
a cell-free scaffold from both PU and PU/HA40 groups were
implanted in each mouse. Afterwards the skin was closed
using staples. After 8 weeks, the mice were euthanized by
CO2-suffocation for sample collection.
Histological analysis
After retrieval, all the in vivo samples were fixed in 10%
phosphate buffered formalin for 30 h and dehydrated
through graded ethanol before embedding in methylmetha-
crylate (MMA, L.T.I., Bilthoven, The Netherlands). Embed-
ded samples were sectioned perpendicularly to the circular
plane of the samples using a microtome equipped with dia-
mond blade (Leica SP1600, Leica microsystem, Wetzlar,
Germany). The sections were stained with methylene blue
and basic fuchsin16 (both reagents from Merck), and
imaged using a light microscope (Zeiss Imager Z1, Carl
Zeiss AG Microscopy, Germany) equipped with AxioCam
MRc5 camera. Three sections from the middle third of each
specimen were used for histological evaluation.
Statistic analysis
Statistical significance in this study was evaluated using
ANOVA analysis followed by Tukey’s Multiple Comparison
Test (GraphPad Software Inc., San Diego, USA). Results
are reported as mean values and standard deviation.




As shown in the SEM micrographs (Fig. 1), the PU and PU/
HA scaffolds displayed a porous structure with the pore size
ranging from 300 to 1000 lm. The pore walls were inter-
connected by the small pores with the diameter ranging
from 50 to 300 lm [Fig. 1(a–c)]. Compared to PU scaffolds,
PU/HA20 and PU/HA40 scaffolds exhibited a less regular
shape of the pores and an unevenness of the pore wall
topography due to the presence of the HA particles [Fig.
1(d–f)].
Biomineralization test
After 1-week immersion in SBF solution, no obvious calcium
phosphate (CaP) precipitation was observed on either PU or
PU/HA20 scaffolds by SEM, whereas EDS detected marginal
quantities of calcium and phosphorus [Fig. 2(a–d)]. In com-
parison, a significant extent of coverage by flake-like crystal
structure was observed on the surfaces of the PU/HA40
scaffold [Fig. 2(f)]. The EDS detected considerable amount
of calcium and phosphorus from these deposits, which con-
firmed the formation of CaP [Fig. 2(e)]. These flake-like CaP
depositions formed a dense multi-layer crystal structure
when the immersion period reached 4 weeks [Fig. 3(f)].
EDS also confirmed a more pronounced signal of calcium
FIGURE 1. SEM micrographs of the PU (a, d), PU/HA20 (b, e), and PU/HA40 (c, f) scaffolds. The PU and PU/HA scaffolds displayed a porous
structure. PU/HA20 and PU/HA40 scaffolds exhibited a less regular pore shape compared to PU scaffolds (a–c). In the magnified figures (d–f), an
increased unevenness on pore surfaces of PU/HA20 and PU/HA40 was observed. (White arrow indicates the interconnection of pores.) [Color fig-
ure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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and phosphorus on the PU/HA40 scaffolds [Fig. 3(e)]. By
contrast, only limited CaP crystal deposition was observed
to scatter on the surface of PU and PU/HA20 scaffolds after
4 weeks [Fig. 3(a–d)].
Cell viability and proliferation
As assessed by the Live/Dead assay, more than 95% of the
cells were viable on all experimental scaffolds after 24 h of
cell seeding (Fig. 4). Furthermore, the DNA contents [Fig.
5(a)], associated with the cell numbers, increased gradually
until day 8 for all groups. On day 16, a decreased DNA con-
tent was detected on all groups compared to that on day 8,
while the amount maintained stable thereafter. At all time
points, the PU/HA20 and PU/HA40 groups displayed a sig-
nificantly enhanced DNA content compared to the PU group.
From day 16 onwards, a higher DNA content was also found
on group PU/HA40 compared to PU/HA20.
Osteogenic differentiation
The expression of ALP activity was measured as a marker
of osteogenic differentiation of the cells [Fig. 5(b)]. Higher
ALP activity was found on the PU scaffolds compared to
PU/HA composite in the early stage of cell culture until day
8. However, the PU/HA40 scaffolds exhibited considerably
higher ALP activity compared to that on PU scaffolds at day
16 and day 24. On RNA level, the PCR results also revealed
that the PU/HA composites, compared to the PU scaffold,
promoted the expression of Bsp and Runx2 at day 4 [Fig.
6(a)], and the expression of Oc at day 8 [Fig. 6(b)].
In vivo evaluation
All animals remained in good health and no signs of
wound complications were observed postoperatively. After
8 weeks, all implanted scaffolds were retrieved. Neither
macroscopic signs of inflammation nor adverse tissue
responses were discerned. Histological observation
showed that all scaffolds (with or without cell seeded)
were encapsulated by a thin fibrous layer (3–6 layers of
fibroblasts) without significant inflammatory cells infiltra-
tion (Fig. 7). Inside of the fibrous capsule, new bone for-
mation (stained red) was observed in all cell-scaffold
constructs for both PU and PU/HA40 groups, which was
present not only at the periphery of the scaffolds [Fig.
7(a,b)], but also penetrated in the core areas (Fig. 8). By
contrast, the implanted cell-free PU/HA scaffolds only
exhibited fibrous capsulation without any bone formation
FIGURE 2. Biomineralization of the scaffolds after 1-week immersion in SBF. EDS detected marginal quantities of calcium and phosphorus on
PU (a) and PU/HA20 (c) scaffolds, while no obvious CaP precipitation was observed on these scaffolds by SEM (b, d). In comparison, significant
coverage by flake-like crystal structure was observed on the PU/HA40 scaffold (f), from which a considerable amount of calcium and phosphorus
were detected by EDS (e). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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[Fig. 7(c)]. Due to the deformation of the scaffolds during
histological processing and the transparency of the PU
scaffolds after being embedded in MMA, quantification of
the bone volume on the scaffolds could not be performed
to determine which group had higher amount of bone for-
mation. Nevertheless, similar bone quality was observed
on the PU and PU/HA40 scaffolds from the histological
evaluation. As shown in Figure 8(a,b), lamellar-like bone
tissue was observed inside of the pores and mainly
aligned along the pore surface. The central area displayed
a bone marrow structure, which was filled with a great
number of hematopoietic cells (stained dark blue) and
adipocytes (with bubble-like morphology) [Fig. 8(c,d)].
Meanwhile, an immature woven bone-like structure was
also found in some pores, which showed the onset of bony
matrix deposition with randomly arranged osteocytes.
FIGURE 3. Biomineralization of the scaffolds after 4-week immersion in SBF. A limited CaP crystal deposit was shown on the surfaces of PU (a,
b) and PU/HA20 (c, d) scaffolds, while a dense multilayer crystal structure with pronounced calcium and phosphorus composition was detected
on the PU/HA40 scaffolds (e, f). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 4. Cell viability on PU (a), PU/HA20 (b), and PU/HA40 (c) scaffolds. More than 95% of the cells were viable on all experimental scaffolds
after 24 h of cell seeding. (Live cells are stained green and dead cells are stained red.) [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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Osteoblasts were observed to align on the periphery of
the newly formed bone matrix [Fig. 8(d)].
DISCUSSION
In the current study, aliphatic PU scaffolds incorporated
with different amounts of HA particles were synthesized by
in situ polymerization and simultaneous foaming method,
subsequently their biological performance for bone tissue
engineering applications was evaluated.
Biomineralization of the PU and PU/HA scaffolds, which
is related to bone-bonding capacity, was evaluated by exam-
ining the apatite formation ability on the scaffold surfaces
by incubating the scaffolds in SBF with ion concentrations
equal to human blood plasma.15 Our results indicated that
the incorporation of 40% HA particles significantly
enhanced the biomineralization ability of the PU scaffolds.
This might be attributed to the partial dissolution of HA
and the subsequent release of calcium ions from PU/HA40
scaffolds, which was more sufficient to favor CaP deposition
compared to that from the PU or PU/HA20 scaffolds. Addi-
tionally, the exposure of HA particles on the surface of PU/
HA40 provided more nucleation sites for CaP formation and
growth.17
Biocompatibility is a primary feature of scaffold materials
for tissue engineering applications. Recently, Williams has re-
evaluated the definition of biocompatibility and pointed out
that biocompatibility of a scaffold should not be solely
dependent on not eliciting any undesirable effects on the
cells or the host as an insertable material.18 More impor-
tantly, the scaffolds should also support the appropriate cel-
lular activity to optimize tissue regeneration.18 Our results
showed that both PU and PU/HA scaffolds maintained the
viability and supported progressive growth of the seeded
cells in vitro. Notably, loading HA particles into the PU matrix
improved the proliferation of the cells. The enhanced cell
growth on the PU/HA composite might be closely related to
the HA particles which increased the initial anchoring and
spreading of serum proteins on the polymer surfaces.19
Moreover, the addition of HA could increase surface oxy-
gen,20 which has been shown to improve the attachment and
proliferation of osteoblast-like cells on biomaterials.21
An enhanced osteogenic differentiation of the seeded
cells has also been demonstrated with the PU/HA scaffolds
by the increase of ALP activity and up-regulation of the
osteogenic-related genes. The up-regulated genes were Bsp
and Runx2, which are important for orienting osteoprogeni-
tors toward the osteo-lineage and regulating the initial
stages of crystal growth,22 and Oc, which is closely related
to the late mineralization process. Addition of HA promoting
osteogenic differentiation of the cells is probably attributed
to two reasons: (1) the increased roughness of the PU/HA
scaffolds and (2) the release of calcium and phosphate from
the PU/HA scaffolds into cell culture medium or the micro-
environment of the seeded cells. Previous studies have
shown that an increased roughness in three-dimensional
scaffolds resulted in an enhanced osteogenic differentia-
tion.23 However, such topography is expected to have a lim-
ited impact when a highly porous and interconnected
scaffold is applied, as it will only be effective for the cells
directly attached on the rough surface but not those present
FIGURE 5. DNA contents (a) and ALP activity (b) on PU, PU/HA20, and
PU/HA40 scaffolds. *p< 0.05, **p<0.01; error bars represent standard
deviation (n 5 3).
FIGURE 6. Expression of osteogenic related genes. Compared to PU, the PU/HA scaffolds promoted the expression of Bsp and Runx2 at day 4
(a), and Oc at day 8 (b). *p< 0.05, **p<0.01; error bars represent standard deviation (n 5 4).
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in the pores.24 Thus, we speculate that the calcium and
phosphate release from HA represents a more effective dif-
ferentiation signal. Our data is consistent with other studies,
which showed that HA provides a favorable environment for
osteoblast-like cell differentiation.25,26
The engineered cell-scaffold constructs were further
implanted subcutaneously to gain insight in their role to sup-
port osteogenic differentiation of the cells after transplanta-
tion. The reason to choose an ectopic model instead of an
orthotopic model for this study was to eliminate or reduce
the number of variables involved in bone formation present
in a bony environment, for instance bone stimulating cyto-
kines, endogenous progenitor/stem cells, and potentially
bone-stimulating mechanotransduction.27 Our result indi-
cated that the PU and PU/HA40 scaffolds supported the cel-
lular growth in vivo. Furthermore, the cell-scaffold constructs
worked as an osteoinductive complex and were capable of
generating new bone tissue. After 8 weeks of implantation,
the bone was still in an active forming and remodeling
phase.
Due to the sample deformation during the histological
processing, the in vivo degradation of both PU and PU/HA
samples could not be quantified in this study. In theory, the
PU matrix can undergo degradation through the hydrolysis
of ester linkages which were introduced by castor oil.4 The
breakdown of these ester bonds yields hydroxyl and carbox-
ylic groups.7 The acidic carboxyl group accelerates further
hydrolysis and the degradation becomes autocatalytic.6 Pre-
vious results demonstrated an approximate 10% weight
loss of aliphatic PU/HA40 scaffolds after being soaked in
PBS for 8 weeks in vitro.12 Additionally, it is expected that
the PU matrix would undergo a faster degradation in vivo as
the presence of inflammatory cells would also contribute to
this process.28 As an ideal scaffold should possess a degra-
dation profile which matches the rate of neotissue forma-
tion,29 further investigations are necessary to evaluate the
degradation of PU/HA scaffolds in an orthotopic location
and monitor their replacement by the tissue in-growth.
Although the PU/HA40 scaffolds showed higher biomi-
neralization ability and significant enhancement of osteo-
blastic differentiation of the seeded cells in vitro compared
to the PU scaffolds, similar quality of the ectopic bone for-
mation was revealed on these two scaffolds after 8 weeks in
vivo. Previous studies have also shown a lack of correlation
and predictability of in vitro osteogenic marker expression
on subsequent in vivo ectopic bone formation.24,30 One pos-
sible reason might be that, the release of calcium and phos-
phate from PU/HA40 was not sufficient to influence the
cellular behavior and local ionic concentration to trigger
more bone formation or faster bone maturation once
implanted. On the other hand, it should be noted that the
ectopic bone formation occurred in an intradermal environ-
ment, which lacks naturally bone-forming stem cells and
stimulators.27 Such an environment differs from the condi-
tion used for in vitro cell culture where the osteogenic
growth factors and supplements are sufficiently supplied.
Therefore, it is expected that the PU/HA40 scaffolds will
probably show superior behavior in promoting the osteo-
blastic differentiation of osteoprogenitors and/or stem cells
FIGURE 7. Capsulation and bone formation on the periphery of the scaffolds after in vivo implantation. All implanted scaffolds (with or without
cell seeded) were encapsulated by a thin fibrous layer without significant inflammatory infiltration. Inside of the fibrous capsule new bone for-
mation (stained red) was observed in cell-scaffold constructs for both PU/HA40 (a) and PU (b) groups, but not in the cell-free PU/HA scaffolds
(c). (S: scaffolds; black arrow: fibrous capsule). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 8. Bone in-growth to the scaffolds after in vivo implantation.
On both PU/HA40 (a, c) and PU (b, d) constructs with cell seeded,
lamellar-like bone tissue was observed in the core area of the scaf-
folds, mainly aligning along the pore surface. Surrounded by the
bone matrix, a large number of hematopoietic cells and adipocytes
(with bubble-like morphology) were observed, which displayed a
bone marrow structure. (B: bone; BM: bone marrow; S: scaffold).
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
2258 YANG ET AL. PU/HA COMPOSITE SCAFFOLD FOR BONE REGENERATION APPLICATIONS
when applied in orthotopic locations. Our study warrants
further investigation toward a clinical implementation of the
PU/HA scaffolds, including (1) scaling up of the implanted
constructs and (2) orthotopic implantation in an immuno-
competent animal model in which endogenous stem cells,
mechanical load, and biochemical/inflammatory factors are
closely involved in the bone forming process.
CONCLUSIONS
Porous aliphatic PU and PU/HA composite scaffolds were syn-
thesized by a foaming method and their biological performan-
ces were evaluated in this study. The incorporation of 40 wt
% HA nanoparticles into PU significantly promoted the biomi-
neralization ability of the scaffolds and enhanced the in vitro
proliferation and osteogenic differentiation of the seeded
MSCs. In vivo implantation revealed that a considerable
amount of vascularized bone tissue with marrow stroma
development was generated on both PU and PU/HA40 scaf-
fold after 8 weeks. Overall, with improved mechanical
strength and efficacy of supporting osteogenesis, the PU/HA
composite is a potential scaffold for bone regeneration
applications.
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